Heinz Grunze
Overview
Explore the profile of Heinz Grunze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
3620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dines M, Kes M, Ailan D, Cetkovich-Bakmas M, Born C, Grunze H
Front Psychiatry
. 2024 May;
15:1352250.
PMID: 38745778
Background: With similarities in heritability, neurobiology and symptomatology, the question has been raised whether schizophrenia and bipolar disorder are truly distinctive disorders or belong to a continuum. This narrative review...
2.
Altshuler L, Suppes T, Black D, Nolen W, Leverich G, Keck Jr P, et al.
Focus (Am Psychiatr Publ)
. 2024 May;
21(4):430-433.
PMID: 38695005
Objectives: The authors compared the switch rate into hypomania/mania in depressed patients treated with second-generation antidepressants who had either bipolar I or bipolar II disorder. Methods: In a 10-week trial,...
3.
Ljubic N, Ueberberg B, Grunze H, Assion H
Focus (Am Psychiatr Publ)
. 2024 May;
21(4):434-443.
PMID: 38695000
Background: Old age bipolar disorder has been an orphan of psychiatric research for a long time despite the fact that bipolar disorder (BD)-I and II together may affect 0.5-1.0% of...
4.
Grunze H
Expert Opin Pharmacother
. 2023 Oct;
24(18):1985-1992.
PMID: 37817489
Introduction: Comorbidity of substance use disorder (SUD) with schizophrenia, referred to as dual disorder (DD), significantly increases morbidity and mortality compared to schizophrenia alone. A dopaminergic dysregulation seems to be...
5.
6.
Grunze A, Mosolov S, Grunze H, Born C
Front Psychiatry
. 2023 Jan;
13:1114432.
PMID: 36699491
Background: Smoking is a substantial and avoidable risk for physical disability and premature death. Despite a declining tobacco use in the community of developed countries, smoking remains abundant in people...
7.
McIntyre R, Alda M, Baldessarini R, Bauer M, Berk M, Correll C, et al.
World Psychiatry
. 2022 Sep;
21(3):364-387.
PMID: 36073706
Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to treatment. Despite evidence for the efficacy of multimodal-ity interventions, the majority of persons affected by this disorder do not...
8.
von Mucke Similon M, Paasche C, Krol F, Lerer B, Goodwin G, Berk M, et al.
Eur Neuropsychopharmacol
. 2022 Jun;
60:91-99.
PMID: 35665655
The use of randomized clinical trials, in particular placebo-controlled trials, for drug approval, is the subject of long-standing debate in the scientific community and beyond. This study offers consensus recommendations...
9.
Grunze H, Soyka M
Expert Opin Pharmacother
. 2022 May;
23(10):1181-1193.
PMID: 35640575
Introduction: Comorbidity of bipolar disorder (BD) and alcohol use disorder (AUD) is very frequent resulting in detrimental outcomes, including increased mortality. Diagnosis of AUD in BD and vice versa is...
10.
Post R, Leverich G, McElroy S, Kupka R, Suppes T, Altshuler L, et al.
Eur Neuropsychopharmacol
. 2022 Mar;
58:47-54.
PMID: 35227977
Objective: Bipolar patients in the United States (US) compared to those from the Netherlands and Germany (here abbrev. as "Europe") have more Axis I comorbidities and more poor prognosis factors...